Literature DB >> 19230045

Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA.

Eric V Marietta1, Shadi Rashtak, Joseph A Murray.   

Abstract

AIM: To indirectly determine if tissue transglutaminase (tTG)-specific T cells play a crucial role in the propagation of celiac disease.
METHODS: Anti-deamidated gliadin peptide (DGP) and anti-tTG IgA and IgG were measured in the sera of celiac patients (both untreated and treated). The correlations were determined by Spearman's rank correlation test.
RESULTS: In celiac patients, we found a very significant correlation between the production of DGP IgA and IgG (r = 0.75), indicating a simultaneous and ongoing production of these two isotypes reminiscent of oral vaccination studies. However, there was far less association between the production of tTG IgA and tTG IgG in celiac patients (r = 0.52). While tTG IgA was significantly correlated with DGP IgA (r = 0.80) and DGP IgG (r = 0.67), there was a weak correlation between production of anti-tTG IgG and the production of anti-DGP IgA (r = 0.38) and anti-DGP IgG (r = 0.43).
CONCLUSION: These data demonstrate that the production of anti-tTG IgA is directly correlated to the production of anti-DGP IgG and IgA, whereas anti-tTG IgG is only weakly correlated. This result therefore supports the hapten-carrier theory that in well-established celiac patients anti-tTG IgA is produced by a set of B cells that are reacting against the complex of tTG-DGP in the absence of a tTG-specific T cell.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230045      PMCID: PMC2653384          DOI: 10.3748/wjg.15.845

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

Review 1.  Celiac sprue.

Authors:  Richard J Farrell; Ciarán P Kelly
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

2.  IgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in coeliac disease.

Authors:  Lorete Maria da Silva Kotze; Shirley Ramos da Rosa Utiyama; Renato Mitsunori Nisihara; Vanessa Ferreira de Camargo; Sergio Ossamu Ioshii
Journal:  Pathology       Date:  2003-02       Impact factor: 5.306

Review 3.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').

Authors:  M N Marsh
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

4.  Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.

Authors:  Shadi Rashtak; Michael W Ettore; Henry A Homburger; Joseph A Murray
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03-04       Impact factor: 11.382

5.  Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.

Authors:  O Molberg; S N Mcadam; R Körner; H Quarsten; C Kristiansen; L Madsen; L Fugger; H Scott; O Norén; P Roepstorff; K E Lundin; H Sjöström; L M Sollid
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

6.  Diagnosis of celiac sprue.

Authors:  J S Trier
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

7.  Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association?

Authors:  L M Sollid; O Molberg; S McAdam; K E Lundin
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

8.  [Anti-endomysium, anti-reticulin and anti-gliadin antibodies, value in the diagnosis of celiac disease in the child].

Authors:  I Ghedira; R Sghiri; A Ayadi; M T Sfar; A Harbi; A S Essoussi; F Amri; S Korbi; M Jeddi
Journal:  Pathol Biol (Paris)       Date:  2001-02

9.  SAT and serology in adult coeliacs, seronegative coeliac disease seems a reality.

Authors:  K Rostami; J Kerckhaert; B M von Blomberg; J W Meijer; P Wahab; C J Mulder
Journal:  Neth J Med       Date:  1998-07       Impact factor: 1.422

10.  Childhood celiac disease: a long-term analysis of relapses in 91 patients.

Authors:  D H Shmerling; J Franckx
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 Jul-Aug       Impact factor: 2.839

View more
  8 in total

1.  Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody.

Authors:  Shahrooz Rashtak; Shadi Rashtak; Melissa R Snyder; Sean J Pittock; Tsung-Teh Wu; Manish J Gandhi; Joseph A Murray
Journal:  J Neuroimmunol       Date:  2010-11-06       Impact factor: 3.478

2.  Celiac sprue: a unique autoimmune disorder.

Authors:  Shadi Rashtak; Eric V Marietta; Joseph A Murray
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

3.  Assessment of a Test for the Screening and Diagnosis of Celiac Disease.

Authors:  Brunetta Porcelli; Fabio Ferretti; Carla Vindigni; Lucia Terzuoli
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

Review 4.  Celiac disease in the elderly.

Authors:  Shadi Rashtak; Joseph A Murray
Journal:  Gastroenterol Clin North Am       Date:  2009-09       Impact factor: 3.806

5.  Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances.

Authors:  Samantha A Scanlon; Joseph A Murray
Journal:  Clin Exp Gastroenterol       Date:  2011-12-19

Review 6.  Assessing of Celiac Disease and Nonceliac Gluten Sensitivity.

Authors:  N Ontiveros; M Y Hardy; F Cabrera-Chavez
Journal:  Gastroenterol Res Pract       Date:  2015-04-29       Impact factor: 2.260

Review 7.  Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance.

Authors:  Markus Hahn; Alexander F Hagel; Simon Hirschmann; Caroline Bechthold; Peter Konturek; Markus Neurath; Martin Raithel
Journal:  Allergo J Int       Date:  2014-03-19

8.  Assessment of a combination screening assay for celiac disease.

Authors:  Brunetta Porcelli; Fabio Ferretti; Carla Vindigni; Carlo Scapellaato; Lucia Terzuoli
Journal:  Auto Immun Highlights       Date:  2011-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.